What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on Rollins, with analysts unanimously rating it hold. Analysts don't like Rollins as much as competitor Cintas overall. Four out of 12 analysts rate Cintas a buy, compared with zero of two for Rollins. That rating hasn't budged in three months as analysts have remained unchanged in their opinion of the stock.
- Revenue forecasts: On average, analysts predict $321.4 million in revenue this quarter. That would represent a rise of 7.6% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.21 per share.
What our community says:
CAPS All-Stars are solidly behind the stock with 100% assigning it an "outperform" rating. The community at large backs the All-Stars, with 96.6% awarding it a rating of "outperform." Fools are bullish on Rollins, though the message boards have been quiet lately, with only 35 posts in the past 30 days. Rollins has a bullish CAPS rating of five out of five stars that is about on par with the Fool community's assessment.
Rollins' profit has risen year over year by an average of 5.8%. Revenue has now gone up for three straight quarters.
Now let's look at how efficient management is at running the business. Traditionally, margins represent the efficiency with which companies capture portions of sales dollars. The following table shows gross, operating, and net margins over the past four quarters.
Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Rollins, Inc. Weathers the Storm
Hurricanes Harvey and Irma weighed on the pest control specialist's third-quarter earnings.
3 Stocks That Could Soar More Than Salesforce
The king of cloud-based CRM's stock has performed admirably for years, but there are others with an even brighter future.
Rollins, Inc. Enjoys Broad-Based Growth
The Orkin Man is in high demand.